| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10222300 | Biological Psychiatry | 2018 | 46 Pages |
Abstract
This study is the first to implicate CTGF as a prodepressant molecule that could serve as a target for the development of novel therapeutics.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Cortney A. Turner, Vikram Sharma, Megan H. Hagenauer, Sraboni Chaudhury, Angela M. O'Connor, Elaine K. Hebda-Bauer, Robert C. Thompson, Richard M. Myers, William E. Bunney, Jack D. Barchas, Francis S. Lee, Alan F. Schatzberg, Stanley J. Jr., Huda Akil,